当前位置: 首页 > 期刊 > 《心血管病防治知识》 > 2011年第1期 > 正文
编号:12293274
氯沙坦钾对白大衣高血压人群靶器官损伤的保护效应(2)
http://www.100md.com 2011年1月1日 赵宇程 陆备军 杨 澜 庄亚杰 戎立辉 王芳芳
第1页

    参见附件。

     [7]O’Brien ET,Asmar R,Beilin L,et a1.European society of hypertension recommendations for conventional,ambulatory and home blood presure measurement.J Hypertens,2003,21:821-848

    [8]Chobanian AV,Bakris GL,Black HR.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure.JAMA. 2003. 289:2560

    [9]Tsazuki S,Matoba T,Eyuchis,et a1.Angiotensin II type 2 receptor inhibits cell proliferation and activated tyrosine phosphatase [J].Hypertension,1996,28:916

    [10]Pierdomenico SD,Costantini F,Bucci A,et a1.Low-density lipe protein oxidation and vitamins E and C in sustained and white-coat hypertension l J].Hypertension,1998,31(2):621-626

    [11]Sjorklund K,Lind L.Vessby B,et a1.Diferent metabolic predictors of whitecoat and sustained hypertension over a 20-year follow- p pe riod:a population-based study of elderlymen [J].Circulation,2002,106(1):63-68

    [12]Flores L.Recasens M,Gomis R,et a1.Wh coat hypertension in type 1 diabetic patients without nephropathy[J].Am J Hypertens,2000,13(5 Pt 1):560-563

    [13]Ribeiro L.Gam a G,Santos A,et a1.Arterial distensibility in subjects with white-coat hypertension with an d without diabetes or dyslipidaemia:comparison with normotensives and sustained hypertensives[J].Blood Press Monit,2000,11(2):101-104

    [14]Moreira.Alcantara P,Aleantara C,et a1.Cardiac structure and functional alterations in white coat hypertension[J].Am J Hypertens,2003,16(5):172

    [15]朱雅萍,方宁远. 中华老年多器官疾病杂志2005年3月第4卷第1期.Chin J Mult Organ Dis Elderly Mar 2005,4 ( 1):59-60

您现在查看是摘要介绍页,详见PDF附件(1777kb)